162 related articles for article (PubMed ID: 38270684)
1. Microarray data analysis of antileukemic action of Cinnamoylated benzaldehyde LQB-461 in Jurkat cell line.
Thimoteo RRC; Neto PN; Costa DSS; da Mota Ramalho Costa F; Brito DC; Costa PRR; de Almeida Simão T; Dias AG; Justo G
Mol Biol Rep; 2024 Jan; 51(1):187. PubMed ID: 38270684
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biological Evaluation of Cyclic Analogues from Nitrone LQB-278: A New Potential Antileukemia Compound.
Thimoteo RRC; Costa DSS; Martino T; Barcellos JCF; Coelho MGP; Costa PRR; Sabino KCC; Simao T; Dias AG; Justo G
Anticancer Res; 2021 Oct; 41(10):4929-4936. PubMed ID: 34593440
[TBL] [Abstract][Full Text] [Related]
3. The pterocarpanquinone LQB 118 induces apoptosis in tumor cells through the intrinsic pathway and the endoplasmic reticulum stress pathway.
de Sá Bacelar T; da Silva AJ; Costa PR; Rumjanek VM
Anticancer Drugs; 2013 Jan; 24(1):73-83. PubMed ID: 22960938
[TBL] [Abstract][Full Text] [Related]
4. Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias.
Rumjanek VM; Maia RC; Salustiano EJ; Costa PRR
Anticancer Agents Med Chem; 2019; 19(1):29-37. PubMed ID: 29692266
[TBL] [Abstract][Full Text] [Related]
5. 11a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes.
Lemos LG; Nestal de Moraes G; Delbue D; Vasconcelos Fda C; Bernardo PS; Lam EW; Buarque CD; Costa PR; Maia RC
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2119-30. PubMed ID: 27520309
[TBL] [Abstract][Full Text] [Related]
6. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
[TBL] [Abstract][Full Text] [Related]
7. The therapeutical potential of a novel pterocarpanquinone LQB-118 to target inhibitor of apoptosis proteins in acute myeloid leukemia cells.
de Souza Reis FR; de Faria FC; Castro CP; de Souza PS; da Cunha Vasconcelos F; Bello RD; da Silva AJ; Costa PR; Maia RC
Anticancer Agents Med Chem; 2013 Feb; 13(2):341-51. PubMed ID: 22721384
[TBL] [Abstract][Full Text] [Related]
8. LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells.
Maia RC; Vasconcelos FC; de Sá Bacelar T; Salustiano EJ; da Silva LF; Pereira DL; Moellman-Coelho A; Netto CD; da Silva AJ; Rumjanek VM; Costa PR
Invest New Drugs; 2011 Dec; 29(6):1143-55. PubMed ID: 20499132
[TBL] [Abstract][Full Text] [Related]
9. The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors.
Nestal de Moraes G; Castro CP; Salustiano EJ; Dumas ML; Costas F; Lam EW; Costa PR; Maia RC
Int J Oncol; 2014 Nov; 45(5):1949-58. PubMed ID: 25174716
[TBL] [Abstract][Full Text] [Related]
10. LQB-118 Suppresses Migration and Invasion of Prostate Cancer Cells by Modulating the Akt/GSK3β Pathway and MMP-9/Reck Gene Expression.
Martino T; DE Bem GF; Santos SVM; Coelho MGP; Resende AC; Netto C; Costa PRR; Justo G; Sabino KCC
Anticancer Res; 2023 Jan; 43(1):359-367. PubMed ID: 36585169
[TBL] [Abstract][Full Text] [Related]
11. The LQB-223 Compound Modulates Antiapoptotic Proteins and Impairs Breast Cancer Cell Growth and Migration.
Lemos LGT; Longo GMDC; Mendonça BDS; Robaina MC; Brum MCM; Cirilo CA; Gimba ERP; Costa PRR; Buarque CD; Nestal de Moraes G; Maia RC
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614718
[TBL] [Abstract][Full Text] [Related]
12. The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress.
Martino T; Kudrolli TA; Kumar B; Salviano I; Mencalha A; Coelho MGP; Justo G; Costa PRR; Sabino KCC; Lupold SE
Prostate; 2018 Feb; 78(2):140-151. PubMed ID: 29105806
[TBL] [Abstract][Full Text] [Related]
13. Cell Cycle Arrest and Apoptosis Induction by a New 2,4-Dinitrobenzenesulfonamide Derivative In Acute Leukemia Cells.
Alves Almeida P; Schmitz de Souza LF; Franzoni Maioral M; Otto Walter L; Fischer Duarte B; Mattos Santos-Pirath Í; Bauer Speer D; Sens L; Tizziani T; Sena de Oliveira A; Nunes RJ; Santos-Silva MC
J Pharm Pharm Sci; 2021; 24():23-36. PubMed ID: 33735604
[TBL] [Abstract][Full Text] [Related]
14. Fenugreek extract as an inducer of cellular death via autophagy in human T lymphoma Jurkat cells.
Al-Daghri NM; Alokail MS; Alkharfy KM; Mohammed AK; Abd-Alrahman SH; Yakout SM; Amer OE; Krishnaswamy S
BMC Complement Altern Med; 2012 Oct; 12():202. PubMed ID: 23110539
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect and mechanism of action (MOA) of hirsutine on the proliferation of T-cell leukemia Jurkat clone E6-1 cells.
Meng J; Su R; Wang L; Yuan B; Li L
PeerJ; 2021; 9():e10692. PubMed ID: 33604171
[TBL] [Abstract][Full Text] [Related]
16. Viscum articulatum Burm. f. aqueous extract exerts antiproliferative effect and induces cell cycle arrest and apoptosis in leukemia cells.
Mishra R; Sharma S; Sharma RS; Singh S; Sardesai MM; Sharma S; Mishra V
J Ethnopharmacol; 2018 Jun; 219():91-102. PubMed ID: 29555410
[TBL] [Abstract][Full Text] [Related]
17. Dichloromethane fraction of Melissa officinalis induces apoptosis by activation of intrinsic and extrinsic pathways in human leukemia cell lines.
Ebrahimnezhad Darzi S; Amirghofran Z
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):313-20. PubMed ID: 23432355
[TBL] [Abstract][Full Text] [Related]
18. The pterocarpanquinone LQB 118 inhibits inflammation triggered by zymosan in vivo and in vitro.
Lima ÉA; Cavalcante-Silva LHA; Carvalho DCM; Netto CD; Costa PRR; Rodrigues-Mascarenhas S
Int Immunopharmacol; 2020 Jun; 83():106399. PubMed ID: 32193104
[TBL] [Abstract][Full Text] [Related]
19. Acyclovir induces cell cycle perturbation and apoptosis in Jurkat leukemia cells, and enhances chemotherapeutic drug cytotoxicity.
Benedetti S; Catalani S; Palma F; Canonico B; Luchetti F; Galati R; Papa S; Battistelli S
Life Sci; 2018 Dec; 215():80-85. PubMed ID: 30403989
[TBL] [Abstract][Full Text] [Related]
20. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells.
Gajate C; Gonzalez-Camacho F; Mollinedo F
PLoS One; 2009; 4(4):e5044. PubMed ID: 19352436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
